Axsome Therapeutics (AXSM) AGM 2024 summary

Opening remarks and agenda

• The meeting was called to order by the CEO and Chairman, welcoming participants to the 2024 annual meeting held in a virtual-only format, allowing remote participation, voting, and Q&A.

• Rules of conduct were outlined, including procedures for submitting questions and the structure of the Q&A session.

Board and executive committee updates

• Officers and directors were introduced, including the board members and key management team, as well as legal counsel and the independent auditor.

Shareholder proposals

• Three proposals were presented: election of two Class III directors, ratification of the independent auditor, and a non-binding advisory vote on executive compensation.